- Home
- OGN vs PRGO Comparison
OGN vs PRGO Comparison
Compare OGN & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGN
- PRGO
- Stock Information
- Founded
- OGN 1923
- PRGO 1887
- Country
- OGN United States
- PRGO Ireland
- Employees
- OGN N/A
- PRGO N/A
- Industry
- OGN Biotechnology: Pharmaceutical Preparations
- PRGO Biotechnology: Pharmaceutical Preparations
- Sector
- OGN Health Care
- PRGO Health Care
- Exchange
- OGN Nasdaq
- PRGO Nasdaq
- Market Cap
- OGN 4.0B
- PRGO 3.3B
- IPO Year
- OGN N/A
- PRGO 1991
- Fundamental
- Price
- OGN $15.48
- PRGO $25.34
- Analyst Decision
- OGN Hold
- PRGO Buy
- Analyst Count
- OGN 5
- PRGO 4
- Target Price
- OGN $20.80
- PRGO $35.00
- AVG Volume (30 Days)
- OGN 2.9M
- PRGO 1.2M
- Earning Date
- OGN 02-13-2025
- PRGO 02-27-2025
- Dividend Yield
- OGN 7.23%
- PRGO 4.58%
- EPS Growth
- OGN N/A
- PRGO N/A
- EPS
- OGN 3.33
- PRGO N/A
- Revenue
- OGN $6,403,000,000.00
- PRGO $4,392,000,000.00
- Revenue This Year
- OGN $2.06
- PRGO N/A
- Revenue Next Year
- OGN $1.85
- PRGO $4.56
- P/E Ratio
- OGN $4.65
- PRGO N/A
- Revenue Growth
- OGN 2.24
- PRGO N/A
- 52 Week Low
- OGN $13.87
- PRGO $23.14
- 52 Week High
- OGN $23.10
- PRGO $33.46
- Technical
- Relative Strength Index (RSI)
- OGN 50.46
- PRGO 56.23
- Support Level
- OGN $15.26
- PRGO $23.86
- Resistance Level
- OGN $15.90
- PRGO $24.89
- Average True Range (ATR)
- OGN 0.63
- PRGO 0.57
- MACD
- OGN 0.04
- PRGO 0.11
- Stochastic Oscillator
- OGN 35.19
- PRGO 86.55
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.